Method and compositions of treating Parkinsonisms with levodopa

Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Recombinant or stably-transformed bacterium encoding one or...

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

424331, A61K 3112, A61K 31195

Patent

active

041906721

ABSTRACT:
Improved methods are provided for the treatment of the central nervous system dopamine-deficiency diseases (CNS-DADD's), including Parkinson's disease and other parkinsonisms, which comprises the administration of 3',4'-dihydroxy-2-methyl-isopropiophenone (DHMPP) in an amount effective to inhibit the conversion of levodopa to 3-O-methyldopa (OMD) by catechol-O-methyl transferase (COMT). The present method results in a reduction of the dosage of levodopa otherwise required to symptomatically control the CNS-DADD, providing a concomitant reduction in the untoward side effects of levodopa administration. Also provided are novel pharmaceutical compositions of levodopa and DHMPP.

REFERENCES:
patent: 2929848 (1960-03-01), Woodruff et al.
patent: 3790674 (1974-02-01), Rodriguez
patent: 3984545 (1976-10-01), Fril, Jr. et al.
patent: 3991207 (1976-11-01), Sarges et al.
Chem. Abst., vol. 67-8134a (1967).

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Method and compositions of treating Parkinsonisms with levodopa does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Method and compositions of treating Parkinsonisms with levodopa , we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method and compositions of treating Parkinsonisms with levodopa will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-2113484

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.